Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
0.8664
+0.0064 (0.74%)
At close: Jul 8, 2025, 4:00 PM
0.8797
+0.0133 (1.54%)
After-hours: Jul 8, 2025, 7:31 PM EDT

Virax Biolabs Group Market Cap

Virax Biolabs Group has a market cap or net worth of $3.76 million as of July 8, 2025. Its market cap has decreased by -7.40% in one year.

Market Cap
3.76M
Enterprise Value
153.32K
1-Year Change
-7.40%
Ranking
Category
Stock Price
$0.87

Market Cap Chart

Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $3.76M, a decrease of -98.18%. That is a compound annual growth rate of -74.13%.

History

DateMarket Cap% Change
Jul 7, 20253.73M-61.78%
Dec 31, 20249.77M269.37%
Dec 29, 20232.64M-71.76%
Dec 30, 20229.36M-95.48%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 700.84B
Johnson & Johnson 375.37B
AbbVie 334.34B
Novo Nordisk 316.33B
UnitedHealth Group 279.90B
Novartis AG 242.35B
Abbott Laboratories 233.90B
AstraZeneca 218.65B
Market Cap Rankings